These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4914553)

  • 1. [An attempt to prevent lymphoid atrophy in secondary disease of radiation chimeras by means of transplanting the lymphocytes of a recipient].
    Koval'chuk LV; Zaretskaia IuM
    Biull Eksp Biol Med; 1967 Oct; 63(10):82. PubMed ID: 4914553
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of graft-versus-host disease by Fab fragments derived from ALG.
    Richie ER; Gallagher MT; Trentin JJ
    Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From radiation chimeras to 1988.
    van Bekkum DW
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():216-21. PubMed ID: 2565747
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon-gamma-mediated prevention of graft-versus-host disease: development of immune competent and allo-tolerant T cells in chimeric mice.
    Brok HP; Vossen JM; Heidt PJ
    Bone Marrow Transplant; 1997 Mar; 19(6):601-6. PubMed ID: 9085739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on immunologic unresponsiveness during secondary disease. II. The effect of added donor and host immunologically competent cells.
    Thompson JS; Simmons EL; Moy RH; Crawford MK
    J Immunol; 1967 Jan; 98(1):179-85. PubMed ID: 5335178
    [No Abstract]   [Full Text] [Related]  

  • 7. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidonor immunologic reactions of long-standing radiation chimeras.
    van Bekkum DW; Roodenburg J
    Transplant Proc; 1973 Mar; 5(1):881-6. PubMed ID: 4572150
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-dose heparin inhibits acute graft versus host disease in mice.
    Naparstek E; Slavin S; Weiss L; Sidi H; Ohana M; Reich S; Vlodavsky I; Cohen IR; Naparstek Y
    Bone Marrow Transplant; 1993 Sep; 12(3):185-9. PubMed ID: 8241974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine models of graft-versus-host disease with features of scleroderma.
    Charley MR; Deng JS
    Immunol Ser; 1989; 46():625-40. PubMed ID: 2488872
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventive effect of ultraviolet radiation on murine chronic sclerodermatous graft-versus-host disease.
    Mermet I; Kleinclauss F; Marandin A; Guérrini JS; Angonin R; Tiberghien P; Saas P; Aubin F
    Transplantation; 2007 Dec; 84(12):1696-700. PubMed ID: 18165783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of donor lymphocyte infusions following allogeneic bone marrow transplantation.
    van Bekkum DW; Kinwel-Bohré EP
    Exp Hematol; 1997 Jun; 25(6):478-80. PubMed ID: 9197324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor lymphoid cells of Th2 cytokine phenotype reduce lethal graft versus host disease and facilitate fully allogeneic cell transfers in sublethally irradiated mice.
    Fowler DH; Kurasawa K; Smith R; Gress RE
    Prog Clin Biol Res; 1994; 389():533-40. PubMed ID: 7700918
    [No Abstract]   [Full Text] [Related]  

  • 15. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B; Li DP; Xu KL; Pan XY
    Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful prevention of homologous disease in mice using syngeneic hematopoietic cels].
    Fedosov EA
    Biull Eksp Biol Med; 1972 Mar; 73(3):71-4. PubMed ID: 4553424
    [No Abstract]   [Full Text] [Related]  

  • 17. Chimaerism and mortality of irradiated mice injected with allogeneic spleen and bone marrow cells.
    Boranić M; Tomljanović M
    Rev Eur Etud Clin Biol; 1971 Feb; 16(2):161-6. PubMed ID: 4396445
    [No Abstract]   [Full Text] [Related]  

  • 18. Mortality of radiation chimeras in relation to the number of transplanted bone marrow and lymph node cells.
    Vos O
    J Natl Cancer Inst; 1966 Mar; 36(3):431-43. PubMed ID: 18630319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary disease of radiation chimera].
    Zaĭtseva KK
    Arkh Patol; 1967; 29(6):3-11. PubMed ID: 4882591
    [No Abstract]   [Full Text] [Related]  

  • 20. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.